CKD as an Underrecognized Threat to Patient Safety

被引:52
作者
Fink, Jeffrey C. [1 ,2 ]
Brown, Jeanine [1 ]
Hsu, Van Doren [3 ]
Seliger, Stephen L. [1 ,2 ]
Walker, Loreen [3 ]
Zhan, Min [2 ]
机构
[1] Univ Maryland, Sch Pharm, Dept Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Dept Epidemiol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Pharm, Dept Pharmaceut Res Comp, Baltimore, MD 21201 USA
关键词
Patient safety; chronic kidney disease; disease recognition; medical errors; CHRONIC KIDNEY-DISEASE; CHRONIC RENAL-INSUFFICIENCY; GLOMERULAR-FILTRATION-RATE; HOSPITALIZED-PATIENTS; SEVERE HYPERMAGNESEMIA; DIABETES-MELLITUS; HEART-FAILURE; UNITED-STATES; RISK-FACTORS; PREVALENCE;
D O I
10.1053/j.ajkd.2008.12.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is common, but underrecognized, in patients in the health care system, where improving patient safety is a high priority. Poor disease recognition and several other features of CKD make it a high-risk condition for adverse safety events. In this review, we discuss the unique attributes of CKD that make it a high-risk condition for patient safety mishaps. We point out that adverse safety events in this disease have the potential to contribute to disease progression; namely, accelerated loss of kidney function and increased incidence of end-stage renal disease. We also propose a framework in which to consider patient safety in CKD, highlighting the need for disease-specific safety indicators that reflect unsafe practices in the treatment of this disease. Finally, we discuss the hypothesis that increased recognition of CKD will reduce disease-specific safety events and in this way decrease the likelihood of adverse outcomes, including an accelerated rate of kidney function loss and increased incidence of end-stage renal disease. Am J Kidney Dis 53:681-688. (C) 2009 by the National Kidney Foundation, Inc.
引用
收藏
页码:681 / 688
页数:8
相关论文
共 58 条
[1]  
*AH HEALTHC RES QU, 2003, AHRQ QUAL IND GUID P
[2]   Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program [J].
Akbari, A ;
Swedko, PJ ;
Clark, HD ;
Hogg, W ;
Lemelin, J ;
Magner, P ;
Moore, L ;
Ooi, D .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (16) :1788-1792
[3]  
[Anonymous], 1999, ERR IS HUMAN BUILDIN
[4]  
[Anonymous], 1980, EXPLORATIONS QUALITY
[5]   The Canadian Adverse Events Study:: the incidence of adverse events among hospital patients in Canada [J].
Baker, GR ;
Norton, PG ;
Flintoft, V ;
Blais, R ;
Brown, A ;
Cox, J ;
Etchells, E ;
Ghali, WA ;
Hébert, P ;
Majumdar, SR ;
O'Beirne, M ;
Palacios-Derflingher, L ;
Reid, RJ ;
Sheps, S ;
Tamblyn, R .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (11) :1678-1686
[6]   Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients [J].
Biesenbach, G ;
Raml, A ;
Schmekal, B ;
Eichbauer-Sturm, G .
DIABETIC MEDICINE, 2003, 20 (08) :642-645
[7]   Guided medication dosing for inpatients with renal insufficiency [J].
Chertow, GM ;
Lee, J ;
Kuperman, GJ ;
Burdick, E ;
Horsky, J ;
Seger, DL ;
Lee, R ;
Mekala, A ;
Song, J ;
Komaroff, AL ;
Bates, DW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (22) :2839-2844
[8]   Does the patient's payer matter in hospital patient safety? A study of urban hospitals [J].
Clement, Jan P. ;
Lindrooth, Richard C. ;
Chukmaitov, Askar S. ;
Chen, Hsueh-Fen .
MEDICAL CARE, 2007, 45 (02) :131-138
[9]  
Coffey RM, 2005, MED CARE, V43, P48
[10]   Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000 [J].
Coresh, J ;
Byrd-Holt, D ;
Astor, BC ;
Briggs, JP ;
Eggers, PW ;
Lacher, DA ;
Hostetter, TH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (01) :180-188